'It's a Designer Baby!' - Opinions on Regulation of Preimplantation Genetic Diagnosis

UCLA Journal of Law & Technology, Vol. 3, 2005

31 Pages Posted: 8 Feb 2011  

Bratislav Stankovic

United States Patent and Trademark Office

Date Written: February 7, 2005

Abstract

Preimplantation Genetic Diagnosis (PGD) is a procedure that identifies genetic defects in early embryos conceived via In Vitro Fertilization (IVF) techniques. PGD is currently used primarily, if not exclusively, for medical purposes. As the array of possible applications of PGD is expanding, some of the projected uses of genetic screening are controversial, especially those involving non- medical motivations. With the looming array of possibilities associated with genetic screening, some kind of regulation of Preimplantation Genetic Diagnosis is necessary. The regulation should be carefully crafted, and should not be used as a vehicle to promulgate moral views disguised as a federal statute. The decision to conduct prenatal genetic diagnosis tests for various purposes should be made by the couple, after informed consent. The costs of PGD for health purposes should be carried by health insurance in order to prevent social inequalities. A competent authority should safeguard the quality of the genetic tests. Regulation and practice should be in a symbiotic relationship, and they should be constantly informing each other.

Keywords: preimplantation genetic diagnosis (PGD), genetic screening

Suggested Citation

Stankovic, Bratislav, 'It's a Designer Baby!' - Opinions on Regulation of Preimplantation Genetic Diagnosis (February 7, 2005). UCLA Journal of Law & Technology, Vol. 3, 2005. Available at SSRN: https://ssrn.com/abstract=1756573

Bratislav Stankovic (Contact Author)

United States Patent and Trademark Office ( email )

400 Dulany St.
Alexandria, VA 22314
United States

Register to save articles to
your library

Register

Paper statistics

Downloads
2,858
rank
3,583
Abstract Views
12,900
PlumX